Vulvovaginal Candidiasis
📧 Sign up to get email alerts when something new happens for Vulvovaginal Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis [Phase 4]
Phase 4 trial comparing clotrimazole vaginal tablet with fluconazole for severe vulvovaginal candidiasis has completed; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis [Phase 4]
Phase 4 comparative efficacy trial of 10 mg dequalinium chloride (Fluomizin) for vulvovaginal candidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Validity of Patient-Collected Wet Mounts [NA]
This clinical trial update notes the completed status of a study evaluating the validity of patient-collected wet mounts for diagnosing vagi…
-
FDA approval · 2016-08-25FDA Approved: CLOTRIMAZOLE — Supplemental Application (Foster and Thrive (Mckesson /STRATEGIC SOURCING SERVICES LLC))
The FDA approved a supplemental application for clotrimazole, reflecting a regulatory update to its approval.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis [Phase 3]
Phase 3 trial evaluating intra-vaginal total freeze-dried culture of Lcr Regenerans for preventing relapses of recurrent vulvovaginal candid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-23FDA Approved: TERCONAZOLE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Terconazole from Cosette Pharmaceuticals, under ANDA 077553, enabling the marketed generic produ…
-
FDA approval · 2016-02-20FDA Approved: TERCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved a supplemental application for terconazole by E. Fougera & Co. to update labeling for the antifungal product.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
A completed clinical trial compared nucleic acid amplification tests (NAAT) to standard diagnostic methods for vaginitis. The study assessed…
-
FDA approval · 2016-01-21FDA Approved: MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application to market MONISTAT 3 Combination Pack 3 Ovule Inserts containing miconazole nitrate. The product is …
-
FDA approval · 2015-08-20FDA Approved: TERCONAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Terconazole submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-08-10FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 7 7-DAY DISPOSABLE APPLICATORS, a miconazole nitrate vaginal antifungal product, to inc…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) [Phase 3]
A Phase 3 trial comparing ketoconazole plus clindamycin versus tetracycline plus amphotericin B for bacterial vaginosis and vulvovaginal can…
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Comparative Efficacy of Ovule vs Tablet [Phase 3]
A Phase 3 trial conducted to compare the efficacy of a clotrimazole vaginal ovule (Ovulen) versus a clotrimazole vaginal tablet for vulvovag…
-
FDA approval · 2015-07-15FDA Approved: ECONAZOLE NITRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for econazole nitrate from Sun Pharmaceutical Industries, Inc., resulting in an approved update rela…
-
CLINICAL_TRIALS research · 2015-03-25Clinical Trial Update: Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis [Phase 4]
Phase 4 epidemiological update on the evolution/outcomes of patients treated for an acute episode of vulvovaginal candidiasis.
-
FDA approval · 2015-03-14FDA Approved: FLUCONAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for fluconazole from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2015-01-05FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: The Study Of Fluconazole For Vulvovaginal Candidiasis [Phase 3]
Phase 3 clinical trial update for fluconazole in vulvovaginal candidiasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women [EARLY_Phase 1]
This early Phase 1 clinical trial investigates how the vaginal microbiota, metabolome, and environmental toxins relate to reproductive healt…
-
FDA approval · 2014-03-24FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride, an intravenous formulation of fluconazole.
-
FDA approval · 2014-03-10FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 3 COMBINATION PACK containing miconazole nitrate, manufactured by Insight Pharmaceutica…
-
FDA approval · 2014-03-10FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) from Insight Pharmaceuticals LLC, adding a 3-day vaginal t…
-
FDA approval · 2014-03-10FDA Approved: MONISTAT 7 7-DAY DISPOSABLE APPLICATORS — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for Monistat 7 7-day Disposable Applicators, a new applicator-based formulation of miconazole nitrat…
-
FDA label_change · 2014-02-27FDA Approved: MONISTAT 3 3 DAY — Supplemental Application (Insight Pharmaceuticals LLC)
The FDA approved a supplemental application for MONISTAT 3 3 DAY (miconazole nitrate) by Insight Pharmaceuticals LLC, expanding labeling to …
-
FDA approval · 2014-02-27FDA Approved: MONISTAT 3 COMBINATION PACK — Supplemental Application (Insight Pharmaceuticals LLC)
FDA approved a supplemental application for the MONISTAT 3 Combination Pack containing miconazole nitrate, extending its labeling/availabili…